Access cutting-edge non-hodgkin lymphoma treatment through this clinical trial at a research site in Charlotte. Study-provided care at no cost to qualified participants.
Access non-hodgkin lymphoma specialists in Charlotte at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin lymphoma treatment provided free
Brief Summary: This study will test the safety, including side effects, and determine the characteristics of a drug called GEN1160 (PRO1160) in participants with solid tumors and blood cancers. Participants will have cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable) or relapsed or refractory to prior treatments. This Phase 1/2 study will have three parts. The dose escalation part of the study will find out how much and how frequently GEN1160
Sponsor: Genmab
Check if you qualify for this non-hodgkin lymphoma clinical trial in Charlotte, NC
If you're searching for non-hodgkin lymphoma treatment options in Charlotte, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charlotte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.